These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 23580528)

  • 1. Blockade of chronic type I interferon signaling to control persistent LCMV infection.
    Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG
    Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent LCMV infection is controlled by blockade of type I interferon signaling.
    Teijaro JR; Ng C; Lee AM; Sullivan BM; Sheehan KC; Welch M; Schreiber RD; de la Torre JC; Oldstone MB
    Science; 2013 Apr; 340(6129):207-11. PubMed ID: 23580529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interfering with type I interferon: a novel approach to purge persistent viral infection.
    Wilson EB; Brooks DG
    Cell Cycle; 2013 Sep; 12(18):2919-20. PubMed ID: 23974094
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.
    Lee MS; Park CH; Jeong YH; Kim YJ; Ha SJ
    PLoS Pathog; 2013; 9(7):e1003478. PubMed ID: 23874199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.
    Osokine I; Snell LM; Cunningham CR; Yamada DH; Wilson EB; Elsaesser HJ; de la Torre JC; Brooks D
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7409-14. PubMed ID: 24799699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection: the interferon paradox.
    Papatriantafyllou M
    Nat Rev Immunol; 2013 Jun; 13(6):392. PubMed ID: 23648970
    [No Abstract]   [Full Text] [Related]  

  • 8. Confounding roles for type I interferons during bacterial and viral pathogenesis.
    Carrero JA
    Int Immunol; 2013 Dec; 25(12):663-9. PubMed ID: 24158954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology. An interferon paradox.
    Odorizzi PM; Wherry EJ
    Science; 2013 Apr; 340(6129):155-6. PubMed ID: 23580520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.
    Belnoue E; Fontannaz P; Rochat AF; Tougne C; Bergthaler A; Lambert PH; Pinschewer DD; Siegrist CA
    PLoS One; 2013; 8(12):e85302. PubMed ID: 24376875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow viral propagation during initial phase of infection leads to viral persistence in mice.
    Xu HC; Wang R; Shinde PV; Walotka L; Huang A; Poschmann G; Huang J; Liu W; Stühler K; Schaal H; Bergthaler A; Pandyra AA; Hardt C; Lang KS; Lang PA
    Commun Biol; 2021 Apr; 4(1):508. PubMed ID: 33927339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling.
    Hahm B; Trifilo MJ; Zuniga EI; Oldstone MB
    Immunity; 2005 Feb; 22(2):247-57. PubMed ID: 15723812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice.
    Meissner N; Swain S; McInnerney K; Han S; Harmsen AG
    Am J Pathol; 2010 Jun; 176(6):2806-18. PubMed ID: 20395428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection.
    Penaloza-MacMaster P; Barber DL; Wherry EJ; Provine NM; Teigler JE; Parenteau L; Blackmore S; Borducchi EN; Larocca RA; Yates KB; Shen H; Haining WN; Sommerstein R; Pinschewer DD; Ahmed R; Barouch DH
    Science; 2015 Jan; 347(6219):278-82. PubMed ID: 25593185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus.
    Hofer MJ; Li W; Manders P; Terry R; Lim SL; King NJ; Campbell IL
    J Virol; 2012 Jun; 86(12):6932-46. PubMed ID: 22496215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.
    Wilson EB; Kidani Y; Elsaesser H; Barnard J; Raff L; Karp CL; Bensinger S; Brooks DG
    Cell Host Microbe; 2012 May; 11(5):481-91. PubMed ID: 22607801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.